智通财经APP讯，白云山(600332.SH)公告，近日，公司控股子公司广州白云山光华制药股份有限公司(简称“光华药业”)收到澳门特别行政区政府药物监督管理局签发的《中成药注册证明书》，药品名称为小柴胡颗粒(无糖型)[白云山]、小柴胡颗粒[白云山]。
据悉，小柴胡颗粒的功能主治为解表散热、疏肝和胃。用于外感病，邪犯少阳证，症见寒热往来、胸胁苦满、食欲不振、心烦喜呕、口苦咽干。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.